In continuing our search of potent antimalarials based on 8-aminoquinoline structural framework, three series of novel bis(8-aminoquinolines) using convenient one to four steps synthetic procedures were synthesized. The bisquinolines were evaluated for in vitro antimalarial (Plasmodiumfalciparum), antileishmanial (Leishmaniadonovani), antimicrobial (a panel of pathogenic bacteria and fungi), cytotoxicity, β-hematin inhibitory and methemoglobin (MetHb) formation activities. Several compounds exhibited superior antimalarial activities compared to parent drug primaquine. Selected compounds (44, 61 and 79) when tested for in vivo blood-schizontocidal antimalarial activity (Plasmodiumberghei) displayed potent blood-schizontocial activities. The bisquinolines showed negligible MetHb formation (0.2-1.2%) underlining their potential in the treatment of glucose-6-phosphate dehydrogenase deficient patients. The bisquinoline analogues (36, 73 and 79) also exhibited promising in vitro antileishmanial activity, and antimicrobial activities (43, 44 and 76) against a panel of pathogenic bacteria and fungi. The results of this study provide evidence that bis(8-aminoquinolines), like their bis(4-aminoquinolines) and artemisinin dimers counterparts, are a promising class of antimalarial agents.
In continuing our search of potent antimalarials based onn class="Chemical">8-aminoquinoline structural framework, three series of novel bis(8-aminoquinolines) using convenient one to four steps synthetic procedures were synthesized. The bisquinolines were evaluated for in vitro antimalarial (Plasmodiumfalciparum), antileishmanial (Leishmaniadonovani), antimicrobial (a panel of pathogenic bacteria and fungi), cytotoxicity, β-hematin inhibitory and methemoglobin (MetHb) formation activities. Several compounds exhibited superior antimalarial activities compared to parent drug primaquine. Selected compounds (44, 61 and 79) when tested for in vivo blood-schizontocidal antimalarial activity (Plasmodiumberghei) displayed potent blood-schizontocial activities. The bisquinolines showed negligible MetHb formation (0.2-1.2%) underlining their potential in the treatment of glucose-6-phosphate dehydrogenase deficientpatients. The bisquinoline analogues (36, 73 and 79) also exhibited promising in vitro antileishmanial activity, and antimicrobial activities (43, 44 and 76) against a panel of pathogenic bacteria and fungi. The results of this study provide evidence that bis(8-aminoquinolines), like their bis(4-aminoquinolines) and artemisinin dimers counterparts, are a promising class of antimalarial agents.
Authors: S Girault; P Grellier; A Berecibar; L Maes; P Lemière; E Mouray; E Davioud-Charvet; C Sergheraert Journal: J Med Chem Date: 2001-05-24 Impact factor: 7.446
Authors: J Prince Jeyadevan; Patrick G Bray; James Chadwick; Amy E Mercer; Aoife Byrne; Stephen A Ward; B Kevin Park; Dominic P Williams; Rick Cosstick; Jill Davies; Adrian P Higson; Ed Irving; Gary H Posner; Paul M O'Neill Journal: J Med Chem Date: 2004-02-26 Impact factor: 7.446
Authors: Joana Matos; Filipa P da Cruz; Élia Cabrita; Jiri Gut; Fátima Nogueira; Virgílio E do Rosário; Rui Moreira; Philip J Rosenthal; Miguel Prudêncio; Paula Gomes Journal: Antimicrob Agents Chemother Date: 2011-12-12 Impact factor: 5.191
Authors: Nafees Ahmed; Keyur G Brahmbhatt; Shabana I Khan; Melissa Jacob; Babu L Tekwani; Sudeep Sabde; Debashis Mitra; Inder P Singh; Ikhlas A Khan; Kamlesh K Bhutani Journal: Chem Biol Drug Des Date: 2013-04 Impact factor: 2.817
Authors: Luciana Mr Antinarelli; Arturene Ml Carmo; Fernando R Pavan; Clarice Queico F Leite; Adilson D Da Silva; Elaine S Coimbra; Deepak B Salunke Journal: Org Med Chem Lett Date: 2012-05-02
Authors: Marcelo Gomes Davanço; Anna Caroline Campos Aguiar; Leandro Alves Dos Santos; Elias Carvalho Padilha; Michel Leandro Campos; Cleverton Roberto de Andrade; Luiz Marcos da Fonseca; Jean Leandro Dos Santos; Chung Man Chin; Antoniana Ursine Krettli; Rosangela Gonçalves Peccinini Journal: PLoS One Date: 2014-08-18 Impact factor: 3.240
Authors: Anna Caroline C Aguiar; Flávio Jr B Figueiredo; Patrícia D Neuenfeldt; Tony H Katsuragawa; Bruna B Drawanz; Wilson Cunico; Photini Sinnis; Fidel Zavala; Antoniana U Krettli Journal: Malar J Date: 2017-03-09 Impact factor: 2.979